Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Steadview Capital Mauritius Ltd03-05-2018
03-05-2018
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd03-05-2018
Announcement under Regulation 30 (LODR)-Allotment
Allotment of Equity Shares to the shareholders of the Transferor Companies by the Company pursuant to the Scheme of Amalgamation and Arrangement01-05-2018
Newspaper Publication On Notice Of Extra Ordinary General Meeting
Enclosing herewith the copies of newspaper publication on April 18, 2018, of the Notice of the Extra Ordinary General meeting scheduled to be held on Friday, May 11, 2018, published in Financial Express and Andhra Prabha, for the approval of the special business as set out in the Notice18-04-2018
Shareholder Meeting - Extra Ordinary General Meeting On May 11, 2018
An Extra Ordinary General Meeting ('EGM') of the Company will be held on Friday, May 11, 2018, at Hyderabad, for the approval of the special business as set out in the Notice of the EGM. Enclosed a copy of the Notice of the EGM and the same is also available on the website of the Company, www.neulandlabs.com.17-04-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, the details of the Analyst/Institutional Investor meetings held are as attcahed16-04-2018
Shareholding for the Period Ended March 31, 2018
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here16-04-2018
Corporate Action-Updates on Amalgamation/ Merger / Demerger
Update on the Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited (Transferee Company) and Neuland Health Sciences Private Limited (First Transferor Company) and Neuland Pharma Research Private Limited (Second Transferor Company) and their respective Shareholders and Creditors13-04-2018
Neuland Labs: Board approves QIP issue
The board of Neuland Laboratories on Monday approved a qualified placement issue. The company will issue up to 16.75 lakh shares through QIP. The proc09-04-2018
Compliance Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate in compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from a Practicing Company Secretary for the period from October 1, 2017 to March 31, 201809-04-2018